Drug induced liver injury laboratory findings: Difference between revisions
Jump to navigation
Jump to search
YazanDaaboul (talk | contribs) No edit summary |
mNo edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Drug induced liver injury}} | {{Drug induced liver injury}} | ||
{{CMG}} {{AE}} | {{CMG}}; {{AE}} | ||
==Overview== | ==Overview== | ||
Line 17: | Line 17: | ||
* [[Electrolyte]]s | * [[Electrolyte]]s | ||
* Drug levels | * Drug levels | ||
==References== | ==References== |
Revision as of 13:56, 3 August 2016
Drug induced liver injury Microchapters |
Differentiating Drug Induced Liver Injury from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Drug Induced Liver Injury On the Web |
American Roentgen Ray Society Images of Drug induced liver injury |
Risk calculators and risk factors for Drug induced liver injury |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
Laboratory Findings
- CBC
- Alkaline phosphatase
- AST / serum glutamic oxaloacetic transaminase (SGOT)
- ALT / serum glutamic pyruvate transaminase (SGPT)
- Albumin
- Gammaglobulin
- Prothrombin time after vitamin K
- Anti-mitochondrial antibody (AMA)
- Anti smooth muscle antibody (ASMA)
- Urinalysis
- Electrolytes
- Drug levels